Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids

Neuropsychopharmacology

Volumn 37, Issue 4, 2012, Pages 1026-1035

  Bryant, Camron D ^a   Parker, Clarissa C ^a   Zhou, Lili ^b,c   Olker, Christopher ^b,c   Chandrasekaran, Ramalakshmi Y ^d   Wager, Travis T ^d   Bolivar, Valerie J ^e,f   Loudon, Andrew S ^g   Vitaterna, Martha H ^b,c   Turek, Fred W ^b,c   Palmer, Abraham A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d PFIZER INC   (United States)

^e WADSWORTH CENTER   (United States)

^f STATE UNIVERSITY OF NEW YORK   (United States)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

CK 1; DARPP 32; dopamine; opiate; psychomotor; QTL

Indexed keywords

CASEIN KINASE IEPSILON; ENZYME INHIBITOR; FENTANYL; METHAMPHETAMINE; MU OPIATE RECEPTOR AGONIST; PF 4800567; UNCLASSIFIED DRUG;

ADVANCED INTERCROSS LINE; ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CHROMOSOME 15; CONGENIC STRAIN; DBA 2 MOUSE; DRUG SENSITIVITY; FEMALE; GENE INACTIVATION; GENE LOCUS; GENETIC REGULATION; HYPOTHESIS; LOCOMOTION; MALE; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING;

ANALGESICS, OPIOID; ANIMALS; CASEIN KINASE IEPSILON; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG RESISTANCE; FEMALE; GENOME-WIDE ASSOCIATION STUDY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED STRAINS; MICE, KNOCKOUT; MOTOR ACTIVITY; QUANTITATIVE TRAIT LOCI;

EID: 84857041282     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.287     Document Type: Article

References (63)

1. Badura L, Swanson T, Adamowicz W, Adams J, Cianfrogna J, Fisher K et al (2007). An inhibitor of casein kinase I epsilon induces phase delays in circadian rhythms under free-running and entrained conditions. J Pharmacol Exp Ther 322: 730-738. (Pubitemid 47105782)
2. Bailey A, Metaxas A, Al-Hasani R, Keyworth HL, Forster DM, Kitchen I (2010). Mouse strain differences in locomotor, sensitisation and rewarding effect of heroin; association with alterations in MOP-r activation and dopamine transporter binding. Eur J Neurosci 31: 742-753.
3. Bateup HS, Santini E, Shen W, Birnbaum S, Valjent E, Surmeier DJ et al (2010). Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc Natl Acad Sci USA 107: 14845-14850.
4. Belknap JK, Noordewier B, Lame M (1989). Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains. Physiol Behav 46: 69-74. (Pubitemid 19213954)
5. Belknap JK, Riggan J, Cross S, Young ER, Gallaher EJ, Crabbe JC (1998). Genetic determinants of morphine activity and thermal responses in 15 inbred mouse strains. Pharmacol Biochem Behav 59: 353-360. (Pubitemid 28072728)
6. Borgkvist A, Fisone G (2007). Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons. Neurosci Biobehav Rev 31: 79-88. (Pubitemid 44880073)
7. Borgkvist A, Usiello A, Greengard P, Fisone G (2007). Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward. Neuropsychopharmacology 32: 1995-2003. (Pubitemid 47258515)
8. Bottomly D, Walter NA, Hunter JE, Darakjian P, Kawane S, Buck KJ et al (2011). Evaluating gene expression in C57BL/6J and DBA/2J mouse striatum using RNA-Seq and microarrays. PLoS One 6: E17820.
9. Boyle AE, Gill KJ (2008). Confirmation of provisional quantitative trait loci for voluntary alcohol consumption: Genetic analysis in chromosome substitution strains and F2 crosses derived from A/J and C57BL/6J progenitors. Pharmacogenet Genomics 18: 1071-1082.
10. Brase DA, Loh HH, Way EL (1977). Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains. J Pharmacol Exp Ther 201: 368-374.
11. Bryant CD, Chang HP, Zhang J, Wiltshire T, Tarantino LM, Palmer AA (2009a). A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice. Genes Brain Behav 8: 795-805.
12. Bryant CD, Graham ME, Distler MG, Munoz MB, Li D, Vezina P et al (2009b). A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Psychopharmacology 203: 703-711.
13. Bryant CD, Roberts KW, Culbertson CS, Le A, Evans CJ, Fanselow MS (2009c). Pavlovian conditioning of multiple opioid-like responses in mice. Drug Alcohol Depend 103: 74-83.
14. Castellano C, Filibeck L, Oliverio A (1976). Effects of heroin, alone or in combination with other drugs, on the locomotor activity in two inbred strains of mice. Psychopharmacology (Berl) 49: 29-31.
15. Cheng R, Abney M, Palmer AA, Skol AD (2011). QTLRel: An R package for genome-wide association studies in which relatedness is a concern. BMC Genet 12: 66.
16. Cheng R, Lim JE, Samocha KE, Sokoloff G, Abney M, Skol AD et al (2010). Genome-wide association studies and the problem of relatedness among advanced intercross lines and other highly recombinant populations. Genetics 185: 1033-1044.
17. Cheong JK, Virshup DM (2010). Casein kinase 1: Complexity in the family. Int J Biochem Cell Biol 43: 465-469.
18. Collins RL, Whitney G (1978). Genotype and test experience determine responsiveness to morphine. Psychopharmacology (Berl) 56: 57-60. (Pubitemid 8270656)
19. Cox A, Ackert-Bicknell CL, Dumont BL, Ding Y, Bell JT, Brockmann GA et al (2009). A new standard genetic map for the laboratory mouse. Genetics 182: 1335-1344.
20. Cunningham CL, Niehus DR, Malott DH, Prather LK (1992). Genetic differences in the rewarding and activating effects of morphine and ethanol. Psychopharmacology (Berl) 107: 385-393.
21. Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274-5278.
22. Dlugos AM, Hamidovic A, Hodgkinson C, Shen PH, Goldman D, Palmer AA et al (2011). OPRM1 gene variants modulate amphetamine-induced euphoria in humans. Genes Brain Behav 10: 199-209.
23. Fadda P, Scherma M, Fresu A, Collu M, FrattaW(2005). Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice. Synapse 56: 29-38. (Pubitemid 40322361)
24. Falcon E, McClung CA (2008). A role for the circadian genes in drug addiction. Neuropharmacology 56(Suppl 1): 91-96.
25. Flagel SB, Clark JJ, Robinson TE, Mayo L, Czuj A, Willuhn I et al (2011). A selective role for dopamine in stimulus-reward learning. Nature 469: 53-57.
26. Gill KJ, Boyle AE (2008). Genetic influences on drug-induced psychomotor activation in mice. Genes Brain Behav 7: 859-868.
27. Greengard P (2001). The neurobiology of slow synaptic transmission. Science (New York, NY) 294: 1024-1030. (Pubitemid 33041850)
28. Gwynn GJ, Domino EF (1984). Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. I. Acute and chronic effects on mouse locomotor activity. J Pharmacol Exp Ther 231: 306-311. (Pubitemid 15213838)
29. Haertzen CA, Kocher TR, Miyasato K (1983). Reinforcements from the first drug experience can predict later drug habits and/or addiction: Results with coffee, cigarettes, alcohol, barbiturates, minor and major tranquilizers, stimulants, marijuana, hallucinogens, heroin, opiates and cocaine. Drug Alcohol Depend 11: 147-165. (Pubitemid 13130068)
30. Hamidovic A, Dlugos A, Palmer AA, de Wit H (2010). Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-Amphetamine: An exploratory pharmacogenetic study using healthy volunteers. Behav Genet 40: 255-261.
31. Hamidovic A, Dlugos A, Skol A, Palmer AA, de Wit H (2009). Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: An exploratory study with d-Amphetamine in healthy participants. Exp Clin Psychopharmacol 17: 374-383.
32. Heiman M, Schaefer A, Gong S, Peterson JD, Day M, Ramsey KE et al (2008). A translational profiling approach for the molecular characterization of CNS cell types. Cell 135: 738-748.
33. Ho MK, Goldman D, Heinz A, Kaprio J, Kreek MJ, Li MD et al (2010). Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clin Pharmacol Ther 88: 779-791.
34. Hynes MD, Berkowitz BA (1982). Lack of an opiate response to nitrous oxide in mice resistant to the activity-stimulating effects of morphine. J Pharmacol Exp Ther 220: 499-503. (Pubitemid 12152159)
35. Iakoubova OA, Olsson CL, Dains KM, Ross DA, Andalibi A, Lau K et al (2001). Genome-tagged mice (GTM): Two sets of genomewide congenic strains. Genomics 74: 89-104. (Pubitemid 32500269)
36. Keane TM, Goodstadt L, Danecek P, White MA, Wong K, Yalcin B et al (2011). Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 477: 289-294.
37. Levran O, Londono D, O'Hara K, Nielsen DA, Peles E, Rotrosen J et al (2008). Genetic susceptibility to heroin addiction; a candidate-gene association study. Genes Brain Behav 7: 720-729.
38. Li D, Herrera S, Bubula N, Nikitina E, Palmer AA, Hanck DA et al (2011). Casein kinase 1 enables nucleus accumbens amphetamine induced locomotion by regulating AMPA receptor phosphorylation. J Neurochem 118: 237-247.
39. Li X, Jope RS (2010). Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 35: 2143-2154.
40. Lohler J, Hirner H, Schmidt B, Kramer K, Fischer D, Thal DR et al (2009). Immunohistochemical characterisation of cell-type specific expression of CK1delta in various tissues of young adult BALB/c mice. PLoS One 4: E4174.
41. Lott DC, Kim SJ, Cook EH, de Wit H (2006). Serotonin transporter genotype and acute subjective response to amphetamine. Am J Addict 15: 327-335. (Pubitemid 44373578)
42. Lott DC, Kim SJ, Cook Jr. EH, de Wit H (2005). Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30: 602-609. (Pubitemid 40271162)
43. Meng QJ, Logunova L, Maywood ES, Gallego M, Lebiecki J, Brown TM et al (2008). Setting clock speed in mammals: The CK1 epsilon tau mutation in mice accelerates circadian pacemakers by selectively destabilizing PERIOD proteins. Neuron 58: 78-88. (Pubitemid 351467026)
44. Meng QJ, Maywood ES, Bechtold DA, Lu WQ, Li J, Gibbs JE et al (2010). Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes. Proc Natl Acad Sci USA 107: 15240-15245.
45. Middaugh LD, Zemp JW (1976). Effects of methadone on activity and on brain monoamines in two strains of mice. Pharmacol Biochem Behav 5: 367-370.
46. Mizuno M, Kawamura H, Ishizuka Y, Sotoyama H, Nawa H (2010). The anthraquinone derivative emodin attenuates methamphetamine-induced hyperlocomotion and startle response in rats. Pharmacol Biochem Behav 97: 392-398.
47. Mizuno M, Kawamura H, Takei N, Nawa H (2008). The anthraquinone derivative Emodin ameliorates neurobehavioral deficits of a rodent model for schizophrenia. J Neural Transm 115: 521-530.
48. Oliverio A, Castellano C, Eleftheriou BE (1975). Morphine sensitivity and tolerance: A genetic investigation in the mouse. Psychopharmacologia 42: 219-224.
49. Orsini C, Bonito-Oliva A, Conversi D, Cabib S (2005). Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strains. Psychopharmacology (Berl) 181: 327-336. (Pubitemid 41492203)
50. Palmer AA, Verbitsky M, Suresh R, Kamens HM, Reed CL, Li N et al (2005). Gene expression differences in mice divergently selected for methamphetamine sensitivity. Mamm Genome 16: 291-305. (Pubitemid 41160333)
51. Parker CC, Cheng R, Sokoloff G, Lim JE, Skol AD, Abney M et al (2011). Fine-mapping alleles for body weight in LG/J SM/J F(2) and F (34) advanced intercross lines. Mamm Genome 22: 563-571.
52. Parker CC, Cheng R, Sokoloff G, Palmer AA (2011a). Genomewide association for methamphetamine sensitivity in an advanced intercross line. Genes Brain Behav; e-pub ahead of print 27 October 2011; doi:10.1111/j.1601-183X.2011.00747. x.
53. Petkov PM, Cassell MA, Sargent EE, Donnelly CJ, Robinson P, Crew V et al (2004). Development of a SNP genotyping panel for genetic monitoring of the laboratory mouse. Genomics 83: 902-911. (Pubitemid 38469929)
54. Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN et al (2010). High-throughput behavioral phenotyping in the expanded panel of BXD recombinant inbred strains. Genes Brain Behav 9: 129-159.
55. Phillips TJ, Kamens HM, Wheeler JM (2008). Behavioral genetic contributions to the study of addiction-related amphetamine effects. Neurosci Biobehav Rev 32: 707-759.
56. Schuckit MA (2009). An overview of genetic influences in alcoholism. J Subst Abuse Treat 36: S5-14.
57. Singh PP, Junnarkar AY, Seshagirirao C, Kaushal R, Naidu MU, Varma RK et al (1982). A pharmacological study of propane-1,2-diol. Arzneimittelforschung 32: 1443-1446. (Pubitemid 12005549)
58. Utz AC, Hirner H, Blatz A, Hillenbrand A, Schmidt B, Deppert W et al (2010). Analysis of cell type-specific expression of CK1 epsilon in various tissues of young adult BALB/c Mice and in mammary tumors of SV40 T-Ag-transgenic mice. J Histochem Cytochem 58: 1-15.
59. Veenstra-VanderWeele J, Qaadir A, Palmer AA, Cook Jr. EH, de Wit H (2006). Association between the casein kinase 1 epsilon gene region and subjective response to D-Amphetamine. Neuropsychopharmacology 31: 1056-1063.
60. Walton KM, Fisher K, Rubitski D, Marconi M, Meng QJ, Sladek M et al (2009). Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period. J Pharmacol Exp Ther 330: 430-439.
61. Wise RA, Bozarth MA (1987). A psychomotor stimulant theory of addiction. Psychol Rev 94: 469-492.
62. Zhang Y, Svenningsson P, Picetti R, Schlussman SD, Nairn AC, Ho A et al (2006). Cocaine self-Administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32. J Neurosci 26: 2645-2651. (Pubitemid 43357847)
63. Zhou M, Rebholz H, Brocia C, Warner-Schmidt JL, Fienberg AA, Nairn AC et al (2010). Forebrain overexpression of CK1delta leads to down-regulation of dopamine receptors and altered locomotor activity reminiscent of ADHD. Proc Natl Acad Sci USA 107: 4401-4406.